(Q37893776)

24 August 2017

1 reference

title

Consequences of HIV infection on malaria and therapeutic implications: a systematic review (English)

1 reference

24 August 2017

0 references

0 references

1 reference

Clara Flateau

1

1 reference

24 August 2017

Guillaume Le Loup

series ordinal

2

1 reference

24 August 2017

Gilles Pialoux

series ordinal

3

1 reference

24 August 2017

publication date

1 July 2011

1 reference

Lancet Infectious Diseases

24 August 2017

published in

1 reference

24 August 2017

volume

11

1 reference

24 August 2017

issue

7

1 reference

24 August 2017

page(s)

541-556

1 reference

Urbanization, malaria transmission and disease burden in Africa

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Does malaria suffer from lack of memory?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

The burden of malaria in pregnancy in malaria-endemic areas.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Modulation of immune responses during HIV-malaria co-infection in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Placental malaria, maternal HIV infection and infant morbidity.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Malaria attributable to the HIV-1 epidemic, sub-Saharan Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Autopsy study of HIV-1-positive and HIV-1-negative adult medical patients in Nairobi, Kenya

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Review of Human Immunodeficiency Virus Type 1–Related Opportunistic Infections in Sub‐Saharan Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Dual infection with HIV and malaria fuels the spread of both diseases in sub-Saharan Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Exploring 30 years of malaria case data in KwaZulu-Natal, South Africa: part II. The impact of non-climatic factors

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Malaria and HIV: a silent alliance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Causes and empirical treatment of fever in HIV-infected adult outpatients, Abidjan, Côte d'Ivoire

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Effects of trimethoprim-sulfamethoxazole and insecticide-treated bednets on malaria among HIV-infected Ugandan children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Incidence of malaria and efficacy of oral quinine in patients recently infected with human immunodeficiency virus in Kinshasa, Zaire

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Increased severe anemia in HIV-1-exposed and HIV-1-positive infants and children during acute malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Childhood malaria in a region of unstable transmission and high human immunodeficiency virus prevalence

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

HIV infection, malnutrition, and invasive bacterial infection among children with severe malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Malaria and human immunodeficiency virus infection as risk factors for anemia in infants in Kisumu, western Kenya.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Hematological predictors of increased severe anemia in Kenyan children coinfected with Plasmodium falciparum and HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Effects of malaria infection in human immunodeficiency virus type 1-infected Ugandan children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Bacteremia in Malawian children with severe malaria: prevalence, etiology, HIV coinfection, and outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Plasmodium Falciparum malaria and perinatally acquired human immunodeficiency virus type 1 infection in Kinshasa, Zaire. A prospective, longitudinal cohort study of 587 children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

The effect of HIV on morbidity and mortality in children with severe malarial anaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

HIV-1 infection in patients referred for malaria blood smears at government health clinics in Uganda

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Malaria parasitaemia in relation to HIV status and vitamin A supplementation among pre-school children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Childhood malaria parasitaemia and human immunodeficiency virus infection in Malawi.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

The clinical and parasitological presentation of Plasmodium falciparum malaria in Uganda is unaffected by HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Impact of the human immunodeficiency virus type-1 on common pediatric illnesses in Zambia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

High risk of neutropenia in HIV-infected children following treatment with artesunate plus amodiaquine for uncomplicated malaria in Uganda

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Malaria treatment efficacy among people living with HIV: the role of host and parasite factors.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Effect of HIV-1 infection on antimalarial treatment outcomes in Uganda: a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

HIV infection may adversely affect clinical response to chloroquine therapy for uncomplicated malaria in children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

HIV-1 immune suppression and antimalarial treatment outcome in Zambian adults with uncomplicated malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Effects of HIV-1 serostatus, HIV-1 RNA concentration, and CD4 cell count on the incidence of malaria infection in a cohort of adults in rural Malawi

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

HIV immunosuppression and antimalarial efficacy: sulfadoxine-pyrimethamine for the treatment of uncomplicated malaria in HIV-infected adults in Siaya, Kenya.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Safety and tolerability of artemether-lumefantrine versus dihydroartemisinin-piperaquine for malaria in young HIV-infected and uninfected children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Effect of HIV-1 and increasing immunosuppression on malaria parasitaemia and clinical episodes in adults in rural Uganda: a cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

HIV, malaria parasites, and acute febrile episodes in Ugandan adults: a case-control study.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Impact of HIV-associated immunosuppression on malaria infection and disease in Malawi

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Increasing rates of malarial fever with deteriorating immune status in HIV-1-infected Ugandan adults.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Impact of HIV-1 infection on the hematological recovery after clinical malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Falciparum malaria and HIV-1 in hospitalized adults in Maputo, Mozambique: does HIV-infection obscure the malaria diagnosis?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Increased risk for severe malaria in HIV-1-infected adults, Zambia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Outcome and predictive factors of mortality in hospitalized HIV-patients in Burkina Faso.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Cross-sectional relationship between HIV, lymphatic filariasis and other parasitic infections in adults in coastal northeastern Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

The effect of malaria on mortality in a cohort of HIV-infected Ugandan adults

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Prognostic indicators in adult cerebral malaria: a study in Burundi, an area of high prevalence of HIV infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

HIV-1 and parasitic infections in rural Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Human immunodeficiency virus and malaria in a representative sample of childbearing women in Kigali, Rwanda

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

HIV and cerebral malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Relation between falciparum malaria and HIV seropositivity in Ndola, Zambia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Increased prevalence of severe malaria in HIV-infected adults in South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

HIV infection as a cofactor for severe falciparum malaria in adults living in a region of unstable malaria transmission in South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Imported malaria in HIV-infected patients enrolled in the ANRS CO4 FHDH study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Impact of HIV infection on severity of imported malaria is restricted to patients with CD4 cell counts < 350 cells/microl

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Imported malaria in an HIV-positive traveler: a case report with a fatal outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

An update on anemia in less developed countries.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Some haematological parameters in plasmodial parasitized HIV-infected Nigerians.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Interactions between HIV and malaria in non-pregnant adults: evidence and implications

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Host immunity as a determinant of treatment outcome in Plasmodium falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Human immunodeficiency virus seropositivity and malaria as risk factors for third-trimester anemia in asymptomatic pregnant women in western Kenya.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

HIV infection, malaria, and pregnancy: a prospective cohort study in Kigali, Rwanda.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Increased prevalence of malaria in HIV-infected pregnant women and its implications for malaria control

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Malaria, HIV and pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

The effect of dual infection with HIV and malaria on pregnancy outcome in western Kenya

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Prevalence and predictors of maternal peripheral malaria parasitemia in central Mozambique.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

HIV increases the risk of malaria in women of all gravidities in Kisumu, Kenya

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Risk factors for malaria in pregnancy in an urban and peri-urban population in western Kenya

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

The effects of maternal helminth and malaria infections on mother-to-child HIV transmission

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Effect of maternal HIV and malaria infection on pregnancy and perinatal outcome in Zimbabwe

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Maternal HIV infection and infant mortality in Malawi: evidence for increased mortality due to placental malaria infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Association of HIV and malaria with mother-to-child transmission, birth outcomes, and child mortality

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Placental malaria and perinatal transmission of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

The effects of placental malaria on mother-to-child HIV transmission in Rakai, Uganda

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Human immunodeficiency virus co-infection increases placental parasite density and transplacental malaria transmission in Western Kenya.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

The burden of co-infection with human immunodeficiency virus type 1 and malaria in pregnant women in sub-saharan Africa.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Determinants of low birth weight among HIV-infected pregnant women in Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Adverse perinatal outcomes of HIV-1-infected women in relation to malaria parasitemia in maternal and umbilical cord blood.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

HIV, malaria, and infant anemia as risk factors for postneonatal infant mortality among HIV-seropositive women in Kisumu, Kenya

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Breastfeeding and the Risk of Malaria in Children Born to HIV-Infected and Uninfected Mothers in Rural Uganda

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Safety and toxicity of sulfadoxine/pyrimethamine: implications for malaria prevention in pregnancy using intermittent preventive treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Efficacy of sulfadoxine-pyrimethamine for prevention of placental malaria in an area of Kenya with a high prevalence of malaria and human immunodeficiency virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Randomized trial of 2-dose versus monthly sulfadoxine-pyrimethamine intermittent preventive treatment for malaria in HIV-positive and HIV-negative pregnant women in Malawi

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Protecting pregnant women from malaria in areas of high HIV infection prevalence

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Two-dose versus monthly intermittent preventive treatment of malaria with sulfadoxine-pyrimethamine in HIV-seropositive pregnant Zambian women

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Inferiority of single-dose sulfadoxine-pyrimethamine intermittent preventive therapy for malaria during pregnancy among HIV-positive Zambian women.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

A randomized placebo-controlled trial of intermittent preventive treatment in pregnant women in the context of insecticide treated nets delivered through the antenatal clinic

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Effect of sulfadoxine-pyrimethamine resistance on the efficacy of intermittent preventive therapy for malaria control during pregnancy: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Competitive facilitation of drug-resistant Plasmodium falciparum malaria parasites in pregnant women who receive preventive treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Randomized trial of artesunate+amodiaquine, sulfadoxine-pyrimethamine+amodiaquine, chlorproguanal-dapsone and SP for malaria in pregnancy in Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Marked reduction in prevalence of malaria parasitemia and anemia in HIV-infected pregnant women taking cotrimoxazole with or without sulfadoxine-pyrimethamine intermittent preventive therapy during pregnancy in Malawi

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Challenges in the concurrent management of malaria and HIV in pregnancy in sub-Saharan Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Malaria and HIV co-infection in pregnancy in sub-Saharan Africa: impact of treatment using antimalarial and antiretroviral agents

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

HIV-1/parasite co-infection and the emergence of new parasite strains

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Côte d'Ivoire: a randomised trial. Cotrimo-CI Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Effect of co-trimoxazole prophylaxis, antiretroviral therapy, and insecticide-treated bednets on the frequency of malaria in HIV-1-infected adults in Uganda: a prospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Effect of trimethoprim-sulphamethoxazole on the risk of malaria in HIV-infected Ugandan children living in an area of widespread antifolate resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Cotrimoxazole prophylaxis by HIV-infected persons in Uganda reduces morbidity and mortality among HIV-uninfected family members

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Effect of cotrimoxazole prophylaxis taken by human immunodeficiency virus (HIV)-infected persons on the selection of sulfadoxine-pyrimethamine-resistant malaria parasites among HIV-uninfected household members.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Plasmodium falciparum cross-resistance between trimethoprim and pyrimethamine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Impact of trimethoprim-sulfamethoxazole prophylaxis on falciparum malaria infection and disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Dihydrofolate reductase I164L mutations in Plasmodium falciparum isolates: clinical outcome of 14 Kenyan adults infected with parasites harbouring the I164L mutation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Plasmodium falciparum dihydrofolate reductase and dihyropteroate synthase mutations and the use of trimethoprim-sulfamethoxazole prophylaxis among persons infected with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Antimalarial activity of human immunodeficiency virus type 1 protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Antiretrovirals as antimalarial agents.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Stronger activity of human immunodeficiency virus type 1 protease inhibitors against clinical isolates of Plasmodium vivax than against those of P. falciparum.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Antimalarial activity of sera from subjects taking HIV protease inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

HIV protease inhibitors inhibit the development of preerythrocytic-stage plasmodium parasites.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Potencies of human immunodeficiency virus protease inhibitors in vitro against Plasmodium falciparum and in vivo against murine malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Synergy of human immunodeficiency virus protease inhibitors with chloroquine against Plasmodium falciparum in vitro and Plasmodium chabaudi in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Synergistic interactions of the antiretroviral protease inhibitors saquinavir and ritonavir with chloroquine and mefloquine against Plasmodium falciparum in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Antiretroviral protease inhibitors potentiate chloroquine antimalarial activity in malaria parasites by regulating intracellular glutathione metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

HIV protease inhibitors, indinavir or nelfinavir, augment antimalarial action of artemisinin in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

In vitro interactions between antiretroviral protease inhibitors and artemisinin endoperoxides against Plasmodium falciparum.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

HIV and malaria co-infection: interactions and consequences of chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

The potential for interactions between antimalarial and antiretroviral drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Effects of concurrent administration of nevirapine on the disposition of quinine in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Lopinavir/ritonavir affects pharmacokinetic exposure of artemether/lumefantrine in HIV-uninfected healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Lower atovaquone/proguanil concentrations in patients taking efavirenz, lopinavir/ritonavir or atazanavir/ritonavir

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Hepatotoxicity Due to a Drug Interaction between Amodiaquine plus Artesunate and Efavirenz

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

Disease and drug interactions: treating malaria with artesunate plus amodiaquine in patients also receiving treatment for concomitant HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970031-7

7 January 2021

10.1016/S1473-3099(11)70031-7

Identifiers

DOI

1 reference

24 August 2017

1 reference